A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?

In a breakthrough study, scientists found that silencing a single overactive enzyme in the brain reversed early damage caused ...

A drug commonly used for Parkinson’s disease, called pramipexole, has shown strong results in helping people with depression that hasn’t improved with standard treatments. This new finding comes from ...

The study indicates that pesticides and poorer water quality could be the cause of higher rates of the disease.

A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.

Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...

Common cough medicine revealed to slow down Parkinson's disease and dementia - A 12-month study found that Ambroxol helped ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...